Skip to content

Clinical trials

Observational Mesothelioma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Observational Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20121
20134
20151
20164
20181
20192
20201
20213
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Recruiting6
Completed5
Enrolling by invitation2
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Mayo Clinic3
A2 Biotherapeutics Inc.2
ProgenaBiome2
Brigham and Women's Hospital1
Daniel Bernstein1
Mohamed Abdel-Rahman1
National Institutes of Health Clinical Center (CC)1
Pierian Biosciences1
Precision Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma23
Lung Neoplasms7
Pancreatic Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Carcinoma, Renal Cell6
Ovarian Neoplasms6
Thymus Neoplasms6
Breast Neoplasms5
Colonic Neoplasms5
Stomach Neoplasms5

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.